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INTRODUCTION: The stem cell niche is a
complex signaling microenvironment that acts
locally to sustain stem cell activity in tissue
maintenance and regeneration. Although the
cellular constitution and signaling activity of
the stem cell niche is coming into focus in a
variety of tissues, genetic regulatory factors that
specify the niche are less clear. The activity of
such factors is particularly intriguing in organs
such as the breast, where the niche provides
local signals for tissue homeostasis but also
must be entrained by circulating hormones that
induce the dramatic changes of puberty.
RATIONALE: The epithelial stem cells of a
variety of organs respond to secreted signals
generated in subjacent stromal cells, in a
manner often dependent on activity of the
Hedgehog (Hh) signaling pathway. Gli2, which
encodes themajor transcriptional effector of Hh
signaling, is expressed in a subset of stromal cells
adjacent to the ductal epithelium of the mouse
mammary gland and is highly expressed at
terminal end buds and end structures of the
pubertal and adult mammary gland, respec-
tively, which represent the sites of mammary
epithelial stem cells.
RESULTS: Stromal ablation of a conditional
Gli2fl allele with Fsp1Cre, a stromally expressed
recombinase allele (producing Gli2DS mice),
caused a delay in mammary ductal develop-
ment, reduced the number of mammary gland
stromal cells and volume of extracellular matrix,
and caused abnormal mammary duct disten-
sion. Stromal Gli2 ablation did not alter deve-
lopment of the ovary or pituitary, nor their
production ofmammatrophic hormones such as
estrogen or growth hormone, but did affect duc-
tal regeneration, as indicated by a fivefold de-
crease in outgrowth efficiency of mammary
stem cells (MaSCs) transplanted into Gli2DS
mammary glands. These findings suggest that
Gli2 specifies a stromal niche signaling pro-
gram that critically regulates MaSC activity.
FACS-isolatedmammary stromal cells showed
Gli2-dependent expression of factors that stim-
ulate epithelial stem cell renewal, ductal out-
growth, and morphogenesis, including specific
members of the IGF,WNT,FGF, andHGF families
of secreted peptides. Single-cell analysis showed
expression of these factors in a subset of stromal
cells in a manner dependent on Gli2 function.
Receptors for the mammatrophic hormones
estrogen and growth hor-
mone were also expressed
inaGli2-dependentmanner,
and estrogen and growth
hormone treatment of cul-
tured stromal cells induced
these secretedpeptide fac-
tors, suggesting that a critical role of Gli2 in
mammary stromal niche cells is to render these
cells responsive to systemicmammatrophic hor-
mones. Supporting this conclusion, mammary
gland implants of polymer fragments releasing
IGF1 and WNT2 rescued Gli2DS ductal growth
phenotypes, whereas growth hormone–releasing
polymer did not.
CONCLUSION: We find that the Hedgehog
pathway transcriptional effector GLI2 specifies
a stromal cell niche signaling program that
supports mammary epithelial stem cells in
pubertal and virgin adult mice. This program
includes expression of factors such as IGF and
WNT, andGLI2 acts inpart by causing expression
of receptors for hormones such as estrogen and
growth hormone, thus entraining local stem cell
niche activity to systemic mammatrophic hor-
mones.Ourwork illustrates the central role of the
stromal niche in controlling epithelial stem cell
activity and suggests that niche failure may un-
derlie pathogenesis of certain diseases, including
the deficient breast development and hormonal
insensitivity associatedwith the humandisorder,
combined pituitary hormone deficiency. ▪
RESEARCH
Zhao et al., Science 356, 284 (2017) 21 April 2017 1 of 1
The list of author affiliations is available in the full article online.
*These authors contributed equally to this work.
†Corresponding author. Email: pbeachy@stanford.edu
Cite this article as C. Zhao et al., Science 356, eaal3485
(2017). DOI: 10.1126/science.aal3485
Stromal GLI2 coordinates mammary stem cell niche signaling program.Transcriptional regulation by Hedgehog pathway effector GLI2 in stromal
cells of the mammary gland coordinates a hormone-responsive niche signaling program that directs epithelial stem cell activity during the changes of
puberty (schematic, left). Gli2-deficient stromal cells in mouse mammary are unable to support normal ductal outgrowth and morphogenesis of
transplanted, green fluorescent protein–labeled stem cells (right).
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Stromal Gli2 activity coordinates a
niche signaling program for
mammary epithelial stem cells
Chen Zhao,1,2*† Shang Cai,1* Kunyoo Shin,1,2,3 Agnes Lim,1,4 Tomer Kalisky,5
Wan-Jin Lu,1,2 Michael F. Clarke,1 Philip A. Beachy1,2,4,6‡
The stem cell niche is a complex local signaling microenvironment that sustains stem
cell activity during organ maintenance and regeneration. The mammary gland niche must
support its associated stem cells while also responding to systemic hormonal regulation
that triggers pubertal changes. We find that Gli2, the major Hedgehog pathway
transcriptional effector, acts within mouse mammary stromal cells to direct a hormone-
responsive niche signaling program by activating expression of factors that regulate
epithelial stem cells as well as receptors for the mammatrophic hormones estrogen and
growth hormone. Whereas prior studies implicate stem cell defects in human disease, this
work shows that niche dysfunction may also cause disease, with possible relevance for
human disorders and in particular the breast growth pathogenesis associated with
combined pituitary hormone deficiency.
T
he Hedgehog (Hh) signaling pathway reg-
ulates embryonic patterning and postnatal
homeostasis of multiple tissues (1–3), acting
via its major transcriptional effector, GLI2. A
specific function for Gli2 in ductal morpho-
genesis of the mammary gland was suggested by
the defects noted in Gli2−/−mutant mouse embry-
onic mammary gland rudiments engrafted into
adult hosts (4). In addition, breast underdevelop-
ment at puberty is associated with the human
disorder CPHD (combined pituitary hormone de-
ficiency) (5), a substantial subset of which is caused
by loss-of-function or trans-dominant mutations
of the GLI2 gene (6–8). In contrast, Gli2 func-
tion appears to be dispensable for embryonic spec-
ification of mammary gland rudiments, which
instead shows a requirement for expression of
the GLI3 repressor of Hh pathway targets in un-
derlying somitic mesoderm (1, 9–12). Adding fur-
ther complexity to the role of Hh pathway activity,
Gli2 is expressed in the epithelium of embryonic
mammary gland rudiments, whereas Gli2 expres-
sion in pubertal and virgin adult mice occurs ex-
clusively in stromal cells (12).
Periductal Gli2 expression in
developing mammary
To investigate the role of Gli2 in postnatal mam-
mary gland growth, we examined Gli2 expression
in the developing gland and manipulated its ac-
tivity through genetic ablation or hyperactivation.
Gli2 expression occurs intermittently along mam-
mary ducts, and is highly enriched at terminal
end buds of the pubertal gland (5 weeks; Fig. 1,
A and B) and at terminal structures of the adult
female gland (10 weeks; Fig. 1, E and F). These
regions of the pubertal and adult ducts undergo
extensive proliferation and have been suggested
as sites for mammary epithelial stem cells (13–18).
Gli2-expressing cells in cross sections of mam-
mary ducts appear restricted to stromal regions
in both pubertal (Fig. 1, C and D) and adult mam-
mary gland (Fig. 1, G and H), as previously re-
ported (12), and in adult male mammary gland
as well (fig. S1A). This stromal pattern of Gli2
RNA and protein expression was confirmed by
quantitative polymerase chain reaction (qPCR)
and Western blot assays of fluorescence-activated
cell sorting (FACS)–sorted stromal versus lumi-
nal or basal epithelial cells (Fig. 1, I and J, and
fig. S1B). The close proximity of Gli2 expression
to mammary ducts (Fig. 1, A to H) suggests the
possibility of an inductive influence from epithe-
lium inmediating stromal Gli2 expression. Such an
inductive effect was confirmed by the absence of
b-galactosidase (b-Gal) expression in clearedmam-
mary fat pads of Gli2nLacZ/+;NSGmice (Fig. 1K, left
panel) and appearance of stromal b-Gal expression
upon transplantation of cleared fat pads with FACS-
isolated mammary epithelial cells (Fig. 1K, right pa-
nel, blue arrowheads; see Methods). We found that
transforming growth factor–b1 (TGFb1), expressed
in mammary epithelial cells (19), markedly in-
duced expression of Gli2 in FACS-isolated stromal
cells in vitro in a dose-dependent manner (4.5-fold
and 8-fold at 5 and 50 ng/ml, respectively; Fig. 1L).
The dependence of Gli2 expression on TGFb1
signaling was confirmed in vivo by a 2.2-fold
reduction of mammary gland stromal Gli2mRNA
upon treatment of mice with the TGFb receptor
(TGFbR) inhibitor, LY2109761 (Fig. 1M). Response
to TGFb does not include expression of Gli2 in
the mammary epithelium; this and other differ-
ences in epithelial versus stromal responses may
help account for the complexity of TGFb effects on
mammary development and in carcinogenesis (19).
Stromal Gli2 in pubertal
mammary development
To genetically ablate Gli2 function in stromal
cells by site-specific recombination, we exam-
ined the extent of coincident expression of b-Gal
from theGli2nLacZ reporter with Cre recombinase
from the Fsp1Cre allele of the fibroblast specific
protein 1 gene. In mice of the genotype Fsp1Cre;
Rosa26mTmG/+;Gli2nLacZ, Cre recombinase causes
a switch of expression of the membrane-associated
red fluorescent protein mT to expression of the
membrane-associated green fluorescent protein
mG (fig. S1C). In these mice Gli2 promoter activity,
indicated by expression of b-Gal, is enriched in
mG-expressing cells (fig. S1D), and a quantitative
comparison revealed that most cells expressing
b-Gal from theGli2nLacZ allele also expressedmG
(73 ± 12%; Fig. 2, A and B). The Fsp1Cre driver
thus appears suitable for Cre-mediated ablation
of a floxed conditional allele of Gli2 (Gli2fl) in stro-
mal cells of the mammary gland, which is the ex-
clusive site ofGli2 expression inmammary glands
of pubertal and virgin adult females. Fsp1Cre
combinedwithGli2fl/fl orGli2fl/nLacZ, hereafter refer-
red to as Gli2DS (genetic ablation of Gli2 is cha-
racterized in fig. S2A) produceda significant delay of
mammary gland development at pubertal stages (5
weeks; fig. S2B). By adult stages, Gli2DS mice
gradually developed a hypoplastic mammary gland
with greatly enlarged ducts and severely disrupted
terminal end structures (6 to 10 weeks; Fig. 2C and
fig. S3). Histological examination and FACS analy-
sis further revealed reduced levels of type I, type II,
and type IV collagen fibers and a fivefold reduction
in periductal stromal cells (2.3% versus 10.9%; Fig.
2E and fig. S2C). The combinedductal and stromal
abnormality, as measured by the ratio of ductal di-
ameter to stromal thickness (ductal:stromal ratio or
DSR), was highly significant inGli2DSmice (Fig. 2D).
To examine the effect of increased Gli2 activ-
ity, we used Fsp1Cre to drive stromal expression
of SmoM2, which encodes a constitutively activat-
ing form of the seven-transmembrane Smo com-
ponent of the Hedgehog pathway (20, 21), in
mice of the genotype Fsp1Cre;R26SmoM2. These
mice had a maximum life span of 12 weeks (fig.
S4A) but, in sharp contrast to Gli2DS, displayed a
marked expansion of the mammary gland stromal
compartment, as indicated by increased collagen
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expression, a 20-fold increase in the percentage of
stromal cells expressing the proliferative marker
Ki67 (1.2 ± 0.5 versus 23 ± 4), and increased ex-
pression of Gli1 (fig. S4, B to D). Both the stromal
expansion and proliferative effects of stromal
SmoM2 expression were reversed by additional
ablation of Gli2, which functions downstream of
Smo, in mice of the genotype Fsp1Cre;R26SmoM2;
Gli2fl/fl. This reversal demonstrates that SmoM2
effects are dependent on Gli2. The contrasting
effects of Gli2 genetic ablation or hyperactivation
indicate that the overall abundance of stromal
elements within stromal cells is dictated by the
presence and activity of Gli2.
Stromal Gli2 supports mammary stem
cell activity
The developmental delay and terminal defects
in mammary ducts of Gli2DS mice suggested that
ductal epithelial cell proliferation might be im-
paired. We indeed noted a qualitative decrease
in epithelial staining for the Ki67 indicator of pro-
liferative activity in adult mammary gland sec-
tions from Gli2DS mice (fig. S5A) and further found
by quantitative FACS-based analysis a 2.6-fold
reduction of epithelial cells labeled by incorpora-
tion of the nucleoside analog EdU (5-ethynyl-
2′-deoxyuridine) inGli2DS as compared to Gli2WT
mice (1.3% versus 0.5%; Fig. 3A). In contrast,
markers indicative of epithelial differentiation
were not significantly different in their expres-
sion in immunofluorescence staining (fig. S5A),
and the relative proportions of FACS-isolated
luminal versus basal populations in Gli2DS mice
were not notably different from Gli2WT mice
(lower right panels in fig. S5A). To further in-
vestigate reduced levels of proliferation, we cul-
tured mammary epithelial cells from Gli2DS and
Gli2WT mice ex vivo in a Matrigel-based colony-
forming assay. We found that primary epithelial
cells from Gli2WT mice formed three times as
many colonies as cells from Gli2DS mice (Fig. 3B).
Collectively, these data indicate that removal of
Gli2 in Fsp1Cre/+ stromal cells leads to a defect in
the proliferation of the mammary epithelium.
The growth and regeneration of mammary
epithelium depend on the activity of mammary
epithelial stem cells (MaSCs), functionally char-
acterized by measurement of mammary repop-
ulating units (MRUs) upon transplantation of
FACS-isolated cells into cleared mammary fat
pads (22, 23). The activity of MaSCs depends
critically upon signals provided by the mammary
stroma (24). As MaSCs are enriched in myo-
epithelium (22, 23), the basal layer of the mam-
mary epithelium that directly contacts the stromal
environment, we sought to investigate how stromal
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Fig. 1. Gli2 expression in mammary is restricted to stroma and induced
by TGFb. (A and B, E and F) Representative whole-mount carmine alum
stains and b-Gal activity stains (X-Gal) of the fourth mammary gland of
Gli2nLacZ/+ mice at 5-week-old pubertal (A and B) or 10-week-old adult
(E and F) stages (n = 6 animals for each stage). Note heavier X-gal staining at
terminal structures (arrowheads). Scale bar, 500 mm. (C and G) X-gal/Eosin
counterstain and (D and H) CK14/b-Gal immunofluorescence stain of cross
sections showing stromal expression of Gli2 (arrowheads). Scale bar, 50 mm.
(I and J) Stromal cells, epithelial basal cells, and epithelial luminal cells from
10-week-old mice (n = 5) were FACS-isolated and analyzed by qRT-PCR for
Gli2 mRNA expression. Gli2 levels were 6.6, 14.2, 2.0, and 2.3% for total
lineage– (Lin–), stromal, luminal, and basal epithelial cells, respectively. (K) X-Gal
staining showing epithelial cell–induced stromal Gli2nLacZ expression in mam-
mary whole mount (scale bar, 1 mm) and in EosinY counterstained mammary
sections (insets; scale bar, 50 mm). Red arrows point to the vasculature, and
blue arrows point to the transplanted epithelial ducts. n = 3 mice (6 transplants)
per condition. (L) FACS-sorted mammary stromal cells derived from Gli2nLacZ/+
mice were stimulated as indicated, and representative changes of b-Gal activity
were measured and normalized to control samples. n = 3 replicates per
condition. (M) Gli2 qPCR analysis showing reduction of Gli2 transcripts in FACS-
isolated mammary stromal cells of mice treated with TGFb inhibitor, LY2109761,
for 5 days as compared with vehicle treatment (n = 3 mice per treatment).
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loss of Gli2 may affect the epithelial stem cell
niche. To this end, we first compared MaSCs from
Gli2WT or Gli2DS mice in a competitive mammary
gland repopulation assay by FACS isolation of
cells from the upper portion (~50%) of the basal
epithelial cell population (Lin– CD24+ CD49fhigh;
Fig. 1I) of Gli2DS or littermate Gli2WT mice; these
upper basal epithelial cells, enriched in MaSCs
(22, 23), are fluorescent red, as mT expression is
not affected by the stromal Fsp1Cre driver. These
red fluorescent cells were mixed with similarly
FACS-isolated green fluorescent cells [expressing
enhanced GFP (EGFP)] from control mice, and
the mixtures were injected into the left and right
cleared fat pads, respectively, of recipient NSG
animals (Fig. 3C). Within 9 weeks of transplan-
tation, the red fluorescent cells from Gli2WT mice
contributed to the regenerated ductal tree to the
same extent as green fluorescent control cells
(44%:56%), whereas red fluorescent cells from the
Gli2DS mice contributed minimally (7%:93%)
(Fig. 3, C and D, and fig. S5B). Cross sections
of mammary ducts from these transplanted ani-
mals showed no notable differences in periductal
stromal cells and no ductal enlargement in the
outgrowths derived from epithelial cells of Gli2WT
or Gli2DS mice (Fig. 3C). Thus, MaSCs derived from
the upper basal epithelial population from Gli2DS
mice are defective in their regenerative activity,
with reduced colony-forming potential in vitro (Fig.
3B) and a substantially impaired ductal outgrowth
potential in vivo in competitive transplantation
experiments (Fig. 3C).
To further examine the effect of stromal Gli2
function on MaSCs, we measured MRUs of FACS-
isolated upper basal epithelial cells from GFP-
expressing mice upon transplantation into cleared
mammary fat pads of Gli2DS or Gli2WT littermate
mice (Fig. 3E). We found that transplantation into
control host animals with at least one Gli2WT allele
in their mammary stroma generates ductal out-
growths fivefold more efficiently as compared to
Gli2DS hosts (outgrowth efficiencies: 1/618 versus
1/2920; Fig. 3F). Ductal outgrowth in Gli2DS mice
was limited to a small area (<20 mm2), and these
outgrowths were often malformed, with enlarged
mammary ducts and a thin layer of stromal cells
(Fig. 3E and fig. S5C) with reduced Gli2 expres-
sion (fig. S5D). Notably, the difference in MaSC
functional activity measured in these transplanta-
tion assays is solely a function of the Gli2 status of
the host stromal environment, as the donor cells are
from mice that are wild-type except for expression
of GFP. These findings thus suggest that the Gli2
activity in FSP1+ cells controls a niche-signaling
program that regulates mammary stem cell activity
and that this program is disrupted in Gli2DS mice.
Locally acting factors mediate stromal
Gli2 activity
In addition to input from local stromal cells, mam-
mary morphogenesis and the MaSC pool are also
regulated by other factors, including the systemic
hormonal environment (25) as well as immune
cell surveillance (26). We therefore investigated
the possibility that Gli2 activity in other cells or
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Fig. 2. Stromal Gli2 activity is essential for normal mammary develop-
ment. (A) Representative immunostaining showing coincident stromal cell
expression of Gli2nLacZ and Fsp1Cre in mammary sections of Fsp1Cre;Rosa26mTmG/+;
Gli2nLacZ/+ mice. Gli2-expressing cells were pseudocolored in red. Membrane-
localized mGFP encircles nuclear-localized b-Gal. Scale bar, 50 mm. (B) Venn
diagram showing that Fsp1Cre-expressing cells include the majority (73 ± 12%) of
Gli2-expressing cells as well as other stromal cells. (C) Representative whole-mount
carmine alum staining of second and third mammary glands (i, v) and selected
regions of interest (ROI; ii, vi), and H&E staining (iii, vii), and trichrome staining
(iv, viii) of second and third mammary glands in 10-week-old Gli2WTand Gli2DS
littermate mice. Enlarged ducts and disrupted terminal structures in Gli2DS are
apparent (arrowheads in v, vi). The ductal-to-stromal ratio (DSR, panels iii, vii)
is defined as the diameter of the ductal lumen (blue) divided by the total width
of ductal stroma (yellow). Scale bars, 1 mm (i, v), 200 mm (ii, vi), 50 mm (iii, iv,
vii, viii). (D) DSR score, as defined in (C), for ducts of the indicated width
classes in Gli2WT versus Gli2DS mice. A significantly higher DSR of ducts in
various width classes is shown associated with Gli2DS mice (10 ducts of the
indicated width within each class from the second and third mammary glands
of littermate mice were analyzed). (E) Representative analysis of FACS-isolated
stromal cells from littermate Gli2WTversus Gli2DS mice (n = 5) for expression of
Fsp1Cre-activated mGFP. A fivefold reduction of Fsp1-labeled stromal cells in the
Gli2DS mammary gland is shown.
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Fig. 3. Stromal Gli2 supports mammary epithelial
stem cell regeneration. (A) Percentage of EDU+ mammary
epithelial cells as determined by FACS analysis 5 hours
after EDU injection from Gli2WT (Gli2flox/+) and Gli2DS
(Fsp1Cre:Gli2nLacZ/flox) littermate mice (n = 5 per genotype).
(B) Colonies formed per 103 input epithelial cells within
10 days of culture in Matrigel weremeasured in triplicate
from five individual Gli2WT or Gli2DS mice. (C and D) A
Lin–CD24+CD49fhiGFP+ basal epithelial cell population
enriched in MRU was FACS-isolated from EGFPmice and
mixedwith similarly isolated Lin–CD24+CD49fhitdTomato+
basal epithelial cells fromGli2WTorGli2DSmice forcompetitive
repopulation assays.Cellmixtures transplanted into bilateral
pairs of cleared fat padswere analyzed foroutgrowth after
9 weeks. In the representative outgrowths shown, the red
epithelial cells fromGli2WTmice generate a higher proportion
of the outgrowth (44 ± 8.5%) as compared to red epithelial
cellsderived fromGli2DSmice (7±3.5%).Scalebar, 2mm.No
differences in stromal abundancewere noted in trichrome
stainingof cross sections of repopulatedmammary glands.
Scale bar, 50 mm. Ten independent transplants into five
NSGanimals per conditionwere used to generate the bar
graph in Fig. 2D. (E) Lin–CD24+CD49fhiGFP+ cells were
FACS-isolated, serially diluted, and transplanted into
cleared fat pads of immunocompromised (NSG) Gli2WT
or Gli2DS mice. Outgrowths were analyzed by whole-mount
immunostaining, with representative images shown for
outgrowths from transplantations of 2000 cells (E). Cross
sections show no differences of CK14/CK8 expression
in ducts grown in NSG;Gli2WTor NSG;Gli2DS hosts, although
ducts in NSG;Gli2DS hosts were distended. Scale bars,
5 mm (whole mount) and 50 mm (sections). (F) Results from transplantation of a range of cell numbers are shown as total outgrowths and as the proportion
of these outgrowths that are greater than 20 mm2 in size. Outgrowth efficiency is calculated on the basis of total outgrowths by L-CalcTM software of Stem-
Cell Technologies. Data are presented as mean ± SEM, and significance was calculated by an unpaired Student’s t test (*P < 0.05%, **P < 0.01).
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organs affects mammary development. To this
end, we first analyzed coexpression of Fsp1 and
Gli2 in ovary, the major organ for female hor-
mone production (e.g., estrogen and progesterone).
We observed few double-positive cells in corpus
luteum (0.16%, n = 1927), and no coexpression in
follicles (0%, n = 2418) (Fig. 4, A to D), suggesting
that Gli2 ablation is a rare event in the ovaries
of our Gli2DS mice. In addition, and consistent
with the lack of Fsp1 and Gli2 coexpression in
ovary, Gli2WT and Gli2DS mice had statistically
indistinguishable estrogen levels (Fig. 4E, P = 0.5)
that were comparable to those previously reported
(27). We similarly noted little coexpression of Fsp1
and Gli2 in the pituitary and no significant change
in serum growth hormone (GH) or prolactin lev-
els (Fig. 4, F to H). These data collectively suggest
that the Gli2DS mice maintain a hormonal envi-
ronment similar to that of Gli2WT littermates dur-
ing development.
We next investigated potential coexpression of
Fsp1 and Gli2 in mammary macrophages, which
are reported to play a role in mammary develop-
ment during puberty (26). Although we did ob-
serve Gli2 expression in aminuscule fraction (~1%)
of mammary cells expressing the macrophage
marker F4/80 (Fig. 5A, n = 1247), we detected no
Fsp1 expression in F4/80+ cells (Fig. 5B, n = 1248),
indicating that Fsp1Cre-driven ablation of Gli2 in
mammary macrophages is highly unlikely. To fur-
ther exclude a possible defect in mammary mac-
rophages in the Gli2DS phenotype, we transplanted
wild-type stromal cells or macrophages into the
mammary fat pads of pubertal Gli2DS;NSG recip-
ient mice (Fig. 5C). We noted that although stro-
mal cells successfully rescued ductal enlargement
with restoration of periductal collagen and extra-
cellular matrix (Fig. 5, C to F, n = 3), macrophage
transplantation did not provide any rescuing ac-
tivity. These results suggest that macrophages
contribute little if anything to the epithelial ac-
tivity lost in Gli2DS mice. Furthermore, the suf-
ficiency of locally implanted stromal cells to rescue
the Gli2DS mammary phenotype excludes a role for
loss of systemic factors such as pituitary or ovar-
ian mammatropic hormones in the Gli2DS mam-
mary phenotype.
To identify stromal factors induced by Gli2
activity, we compared gene expression of FACS-
isolated Fsp1Cre-marked stromal cells from Gli2DS
or Gli2WT littermates by microarray analysis) and
identified genes encoding paracrine factors such
as Igf1, Wnt2, Hgf, Fgf7, and Bmp7; we also
identified down-regulated genes encoding estrogen
receptor (Esr1), growth hormone receptor (Ghr),
and other genes typically expressed in stromal
cells. Of particular interest among the para-
crine factors, WNT signals sustain the activity of
MaSCs in vivo and in ex vivo culture (28, 29), and
functional inactivation of Igf1 or its epithelially
expressed receptor, Igf-1r, leads to development of
hypoplastic mammary glands with terminal end
bud abnormalities (30, 31), similar to the defects
we observe in Gli2DS mice. The down-regulation
of these genes was confirmed by qRT-PCR of bulk
stromal cells from Gli2WT and Gli2DS mice (Fig. 6A)
and was further quantified by qRT-PCR from
single cells (fig. S6; summarized in Fig. 6B). Igf1
and Wnt2 were expressed in 7% and 9% of indi-
vidual Gli2WT stromal cells, respectively, but in 0%
of Gli2DS stromal cells (Fig. 6B). Our single-cell
analysis was validated by the expression of Gli2
in 19% of Fsp1Cre-marked Gli2WT stromal cells (Fig.
6B), consistent with our immunofluorescence
analyses (Fig. 2, A and B). The Gli2nLacZ reporter
is expressed within the thin stromal layer that re-
mains in Gli2DS mice in a pattern similar to that
of Gli2nLacZ within control mice (Fig. 6C), indi-
cating that these cells may be correctly specified
but fail to function normally, owing to loss of GLI2
protein activity. These results collectively show
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Fig. 4. Stromal Gli2
ablation does not
affect mammatrophic
ovarian or pituitary
hormones. (A to
D) Staining for b-Gal
and FSP1/S100a4
was performed in a
Gli2nLacZ/+ mouse
ovary. b-Gal (green),
FSP1/S100A4 (red), and
nuclei (DAPI, blue) are
shown in corpus luteum
(A and B) and follicle
(C and D). Quantitative
analysis (B and D)
involved counting more
than 2000 cells. Scale
bar, 100 mm. (E) Serum
from Gli2WT (n = 12) and
Gli2DS (n = 8) mice was
collected and probed for
estrogen level by ELISA.
No significant difference
was found between wt
and Gli2DS mutant
groups (P = 0.5). (F)
Representative H&E
(left) immunostaining
(middle and right)
showing that Gli2-
expressing cells are dis-
tinct from Fsp1Cre-
labeled cells in the
anterior lobe of
pituitary gland in
Fsp1Cre;Rosa26mTmG/+;
Gli2nLacZ/+ mice. b-Gal (Gli2)–expressing cells were pseudocolored in red.The lack of Gli2 expression in the posterior lobe of the pituitary gland is apparent. (G and
H) Quantification of growth hormone and prolactin levels in serum by ELISA in Gli2WTor Gli2DS mice.
RESEARCH | RESEARCH ARTICLE
o
n
 June 14, 2019
 
http://science.sciencem
ag.org/
D
ow
nloaded from
 
that the Gli2 transcription factor is critical for ex-
pression of mammary stem cell niche signals.
Mammatrophic hormone response
requires stromal Gli2
Previous studies have shown that MaSCs respond
to the mammatrophic hormones estrogen and
GH (32, 33). MaSCs do not, however, express the
receptors for these hormones (34), indicating that
the mammatrophic hormone effect is indirect.
Mammary stroma is an important mediator of
hormone effects onMaSC activity (24), and we find
that expression of estrogen receptor and GH re-
ceptor is markedly reduced, from 7 and 14%,
respectively, to 2% of individual stromal cells in
Gli2DS mice (Fig. 6B). We therefore examined the
Gli2 dependence of hormone response in FACS-
isolated Fsp1Cre-marked mammary stromal cells
and indeed found that stimulation with GH or
with estrogen revealed significantly impaired induc-
tion of their target genes Igf1 or Hgf, respectively,
in cells from Gli2DS as compared to Gli2WT mice
(2.88-fold reduction for Igf1 and 3.16-fold reduc-
tion for Hgf; Fig. 6, D and E), reflecting the
significant reduction in expression of receptors
for these hormones (fig. S7).
These defects in hormonal response of mam-
mary stroma are reminiscent of the incomplete
response of patients suffering from the disorder
CPHD to hormonal supplementation. This supple-
mentation is provided because multiple peptidic
pituitary hormones and steroidal hormones in-
duced by pituitary hormones are deficient as a
result of the congenital hypopituitarism associated
with CPHD. Supplementation with GH rescues
height defects in these patients (35, 36), but ab-
normal breast development often is not improved,
even with estrogen supplementation (5). Gli2DS
mice produce normal levels of pituitary hormones
such as GHand prolactin (Fig. 4, G andH), asGli2
expression in the pituitary is not affected (Fsp1Cre
and Gli2nLacZ expression in the pituitary do not
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Fig. 5. Effects of Gli2 ablation in Gli2DS mice are mediated by mam-
mary stromal cells. (A) Mammary gland from a 6-week-old Gli2nLacZ/WT
mouse was paraffin sectioned and stained for b-Gal (Gli2 expression) and
F4/80 (macrophage marker). Sections containing terminal end buds (TEBs)
were analyzed and quantified for Gli2 (green) and macrophage (red) costaining.
Scale bar, 100 mm. (B) Mammary gland from a 6-week-old wt mouse was
paraffin sectioned and stained for FSP1/S100A4 and the macrophage marker
F4/80. Sections containing TEBs were analyzed and quantified for FSP1/
S100A4 (green) and macrophage (red) costaining. Scale bar, 100 mm. (C)
Fsp1-expressing stromal cells and macrophages were sorted from an Fsp1Cre;
mTmG;Gli2nLacZ/+ mouse mammary gland and injected into the fat pads of
Fsp1Cre;Gli2fl/fl;NSG recipient mice. Two months after injection, recipient mice
were euthanized for whole-mount analysis. (D) Fsp1-expressing stromal cells
rescue mammary duct enlargement, whereas macrophages do not. N = 3
experimental repetitions. (E and F) Mammary glands from Gli2DS;NSG recipients
with injected donor macrophages and stroma were collected and sectioned for
H&E staining, and DSR (ratio of ductal diameter, blue arrow, to total stromal width,
yellow arrow) was determined as in Fig. 2. P < 0.01. Error bars indicate SD.
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overlap; Fig. 4F). Despite intact pituitary hormone
production, however, Gli2DS mice nevertheless
show abnormal mammary gland development,
as described above.Gli2DSmice thus do not share
the pituitary hormonal deficiencies of CPHD
patients but do share the resistance to hor-
mone treatments, which likely contributes to
the pathogenesis of mammary abnormalities
in CPHD patients. Consistent with this inter-
pretation, we find that hGLI2, like mGli2, is
expressed predominantly in stromal breast cells
(fig. S8).
If, as our findings suggest, stromal Gli2 me-
diates hormonal response and the expression of
niche signals that support epithelial stem cell
activity, it should be possible to rescuemammary
defects seen in Gli2DS mice by providing missing
niche signals from an exogenous source. We
therefore tested the effect of slow-release poly-
mer implants containing secreted protein signals
in the intact mammary of Gli2DS mice, focusing
in particular on insulin-like growth factor 1 (IGF1)
and a canonical WNT family protein because of
thewell-established roles of these signals inmam-
mary development (28–31), and using GH as a
control. Ex vivo assays showed that GH, IGF1, and
WNT2b proteins embedded in the slow-release
polymer, poly(ethylene-co-vinyl acetate) (Elvax40),
were gradually released over 2 to 8 days and were
able to stimulate pathway-specific target genes
(fig. S9, A to G). For in vivo experiments, the
effects of control or factor-containing polymer
implants surgically placed in themammary glands
ofGli2DS mice were assessed after 7 days by whole-
mount analysis and qPCR (Fig. 7A).
We indeed confirmed, that, although GH-
containing Elvax40 implants increased the num-
ber of terminal structures fivefold inGli2WT;NSG
hostmice (5.625 ± 1.21; fig. S10, B and C), inGli2DS;
NSG mice these implants failed to stimulate Igf1
expression and did not change terminal structure
growth at the implantation site (Fig. 7, B to D). In
contrast to GH, IGF1-containing implants in-
creased terminal structure formation in the vicinity
of the implants sevenfold in pubertal (psd40) and
fivefold in adult (psd70) Gli2DS mice (Fig. 7, E and
F, and fig. S10A). IGF1 target genes Egr1 andM-Csf
also were reliably induced near the site of the im-
plants (Fig. 7G), confirming the efficacy of IGF1
delivery. As compared to IGF1 alone, implants
containing both IGF1 andWNT2b showed an even
greater effect in inducing a 13-fold increase in
terminal structure growth at the adult stage (Fig.
7, H and I) in Gli2DS mice and consistently in-
duced the expression ofM-Csf andAxin2 (Fig. 7J);
Axin2 expression indicates Wnt response, which
promotes the survival and self-renewal ability of
mammary epithelia (29). Together these results
suggest that, although themammary abnormalities
in Gli2DS mice fail to respond to GH stimulation,
the terminal growth defects of the mammary
ductal tree can be rescued in part by local sup-
plementation with the GLI2-dependent paracrine
factors IGF1 and WNT2b.
Conclusions
Although the cellular constitution and signaling
activity of the stem cell niche is coming into focus
in a variety of tissues, the genetic regulatory
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Fig. 6. Stromal Gli2 regulates a niche signaling program for mammary
stem cell activity. (A) Fsp1Cre-labeled mammary stromal cells FACS-isolated
from Gli2WT (Fsp1Cre;Rosa26mTmG/+) or Gli2DS (Fsp1Cre;Rosa26mTmG/+;Gli2flox/nLacZ)
littermate mice were analyzed by qRT-PCR for expression of selected genes,
shown as a percentage of HPRT expression, and measured in triplicate from
each of three individual Gli2WTor Gli2DS mice.Three major classes of stromally
expressed genes are down-regulated in stromal cells of Gli2DS mice (see text).
(B) Gene expression in single, FACS-isolated Fsp1Cre-labeled stromal cells
from Gli2WT and Gli2DS mice was analyzed by qRT-PCR. The results (fig. S4)
are summarized here as the percentage of single cells analyzed that express
the indicated genes. (C) Sections of Gli2WT (Fsp1Cre;Rosa26mTmG/+;Gli2nLacZ/+)
and Gli2DS (Fsp1Cre;Rosa26mTmG/+;Gli2nLacZ/flox) mammary glands immuno-
stained for collagen and b-Gal. Selected areas (dotted lines) are shown at
higher magnification in the green channel only (b-Gal–expressing cells) in the
right panels.The frequency of b-Gal–labeled cells per 100-mm length of ductal
epithelium is shown in the lower left of the right panels. Scale bar, 50 mm. (D and
E) Fsp1Cre-labeled mammary stromal cells FACS-isolated and cultured from
Gli2WT or Gli2DS mice were stimulated with murine growth hormone (mGH)
(D) or 17b-estradiol (E) for 24 hours and assayed for expression of Igf1 or Hgf,
respectively. Expression of Igf1 and Hgf in Gli2DS is reduced as compared to
Gli2WT. Measurements in panels (D) and (E) were made in triplicate from each
of three individual Gli2WT or Gli2DS mice. Error bars indicate SEM.
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factors that specify the niche and thus create a
favorable environment for stem cell function
have not been identified. The activity of such
factors is particularly intriguing in organs such
as the breast, where the niche provides local
signals for tissue homeostasis but also must be
entrained by circulating hormones that induce
the dramatic changes of puberty. Using a Gli2nLacZ
reporter and a stromal-specific Cre driver, we find
that Gli2 is predominantly expressed in periductal
stroma of themammary gland of pubertal and vir-
gin adult mice and encodes a functionally critical
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Fig. 7. Slow-release IGF1, WNT2B polymer implants rescue epithelial
growth defects in Gli2DS mice. (A) Schematic of slow-release polymer-
based implantation experiments to test activity of GH, IGF1, and combined
IGF1/WNT2B. (B) Control and GH-containing polymers (dashed lines) were
implanted bilaterally into immunodeficient Gli2DS (NSG: Gli2DS) mice, and
ductal morphology was examined 7 days after implantation (n = 3 implan-
tations; one representative image of three is shown). Scale bar, 1 mm. (C)
Numbers of terminal structures within 2 mm of the implantation site are
shown as fold increase relative to control implants. (D) Induction of Igf1 in-
duction in control and GH-containing implants. GH failed to induce terminal
growth or Igf1 expression in NSG;Gli2DS mice. (E) Control and IGF1-containing
polymers (dashed lines) were implanted bilaterally into NSG;Gli2DS mice at
pubertal (p40) or adult (p70) stages. Ductal morphology was examined after
7 days (n = 3 implantations; one representative image of three is shown).
Scale bar, 1 mm. (Fand G) Numbers of terminal structures (F) within 2 mm of
implants and IGF1-induced expression of Egr1 and M-Csf (G) were calculated
and normalized to control implants. (H) Control and IGF1/WNT2b-containing
polymers (dashed lines) were implanted bilaterally into NSG;Gli2DS mice,
followed by morphological analyses after 7 days (n = 3 implantations; one
representative image of three is shown). Scale bar, 1 mm. (I and J) Numbers
of terminal (I) structures and induction of IGF1 or WNT2b target genes (J)
were quantified as fold increase relative to control implants. IGF1/WNT2b
implants induce more terminal end growth as compared to IGF1 alone. Data
are normalized to the mean values in the control and are presented as mean
± SEM; statistical significance was calculated by an unpaired Student’s t test
(*P < 0.05%, **P < 0.01).
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regulator that specifies niche activity in support
of mammary epithelial stem cells (Fig. 8). One
aspect of this regulatory activity is the induction,
direct or indirect, of stem cell support factors,
including IGF and WNT signaling proteins. The
GLI2 transcription factor thus appears to control
the niche signaling program for MaSCs. Gli2DS
mice lacking stromal Gli2 function consequently
suffer from a severe defect in regenerative activity
of epithelial stem cells. A second aspect of Gli2
activity is the induction of receptors for mamma-
trophic hormones such as growth hormone and
estrogen in stromal cells such that they become
competent to respond to circulating hormones,
thereby placing niche signaling activity under
hormonal control. This hormonal response is
also lost in Gli2DS mice (Fig. 8). Thus, our anal-
ysis provides insight into the mechanism that
coordinates systemic mammatrophic hormone
action and activity of the local epithelial stem
cell niche, namely, that a single transcription
factor, GLI2, controls both the expression of
hormone receptors and the stromal niche sig-
naling program.
Our findings in Gli2DS mice imply that a de-
fective stem cell niche environment may under-
lie the pathogenesis of breast defects seen in the
human disorder CPHD. Although several degen-
erative and aging-related diseases have been
tentatively ascribed to defects in stem cells them-
selves, dysfunction of a supporting niche has not
previously been linked to human disease (37). By
indicating that niche failure can cause disease,
our study asserts the central role of the niche in
controlling stem cell activity and raises the pos-
sibility of niche dysfunction in other human
diseases. Furthermore, by showing that Gli2-
dependent mammary niche signaling factors
can rescue aspects of theGli2DSmammary inmice,
our work suggests a potential therapeutic inter-
vention for patients with hormone-refractory
CPHD.
Methods
Mice
Female mice at pubertal (5 weeks) or adult
(10 weeks) stages were used for all experiments.
Gli2nLacZ mice (38) were first bred with Gli2flox
mice (39), then with Rosa26mTmG/+ mice (40), to
generate Gli2flox/nLacZ or Gli2nLacZ/+;Rosa26mTmG/+
mice. Fsp1Cre mice (41) were crossed toGli2flox/flox to
generate Fsp1Cre;Gli2flox/+ or with Rosa26mTmG/mTmG
mice to generate Fsp1Cre;Rosa26mTmG/+ strain.
Fsp1Cre;Gli2flox/+ mice were then crossed with
Gli2flox/nLacZ mice to obtain littermateGli2flox/+
and Fsp1Cre;Gli2flox/nLacZ mice. The Fsp1Cre;
Rosa26mTmG/+ strain was crossed to Gli2flox/flox
strain to generate Fsp1Cre;Rosa26mTmG/+;Gli2flox/+
mice which were subsequently bred to Gli2nLacZ/+;
Rosa26mTmG/+ to obtain littermate Fsp1Cre;
Rosa26mTmG/+, Fsp1Cre;Rosa26mTmG/+;Gli2nLacZ/+
and Fsp1Cre;Rosa26mTmG/+;Gli2nLacZ/flox mice. NSG
mice were extensively bred and back-crossed with
Fsp1Cre;Gli2nLacZ/flox through six generations to
obtain Gli2flox/+;NSG, Gli2nLacZ/+;NSG, Fsp1Cre;
Gli2flox/flox;NSG, and Fsp1Cre;Gli2nLacZ/flox;NSG
mice. All mouse strains were obtained from
Jackson Laboratories, except as otherwise indi-
cated. For each experiment, mice of the same
genotypes were randomly selected for experi-
ments and investigators were blinded for out-
come assessment. All procedures were performed
under an assigned protocol (14586) approved by
the Administrative Panel on Laboratory Animal
Care (APLAC) at Stanford University.
Antibodies and reagents
The following antibodies were purchased: chicken
polyclonal anti-b-Gal antibody (Abcam, CAT:ab9361),
rabbit polyclonal anti-CK14 antibody (Covance,
CAT:PRB-155P), rabbit polyclonal anti-Ki67 anti-
body (Abcam, CAT: ab15580), Cy3-conjugated
mouse monoclonal anti-smooth muscle actin
antibody (Sigma, CAT: C6198), rat anti-CK8 anti-
body (DSHB, TROMA-I), rabbit polyclonal anti-
collagen I antibody (Abcam, CAT: ab21286), goat
polyclonal anti-NKCC1 antibody (Santa Cruz,
CAT:sc-21545), guinea pig anti-Gli2 antibody was
obtained from Dr. Eggenschwiler at University
of Georgia, APC (allophycocyanin)–conjugated
rat anti-mouse F4/80 (Biolegend), rabbit polyclo-
nal anti-S100a4 (Biolegend). Dylight 488-labeled
goat anti-chicken IgY, Alexa 488-labeled donkey
anti-rabbit immunoglobulin G (IgG) and Alexa 647-
labeled donkey anti-goat IgG were purchased from
Jackson ImmunoResearch. Alexa 488-labeled goat
anti-rabbit IgG, Alexa 594-labeled goat anti-
rabbit IgG, and Alexa 647-labeled goat anti-rat
IgGwere purchased from Invitrogen. Trichrome
straining kit (25088-100) was purchased from
Polysciences Inc. Rat/mouse growth hormone
enzyme-linked immunosorbent assay (ELISA) kit
was purchased from Millipore (EZRMGH-45K).
Mouse prolactin ELISA kit was purchased from
Abcam (ab100736).Mouse Igf1 ELISA kit was pur-
chased fromRaybiotech (ELM-IGF1).MouseWnt2B
ELISA kit was purchased from MYBioSource
(MBS946031). Click-IT®Plus EdU Alexa Fluor®647
flow cytometry assay kit (C10634) was purchased
from Invitrogen. Poly(ethylene-co-vinyl acetate)
(Elvax40) beads (340502)were purchased fromSig-
ma. Recombinant mouse Igf1 (791-MG-050) and
recombinant mouse Wnt2b (customized quantity)
were purchased from R&D Systems. Mouse growth
hormone (CYT-540) was purchased from Prospec-
bio. 48.48DynamicArrayChips (BMK-M.48.48) for
single-cell analysis were purchased fromFluidigm.
Ortho-nitrophenyl-b-galactoside (ONPG) was pur-
chased from Thermo-Scientific (catalog no. 34055).
TGFbRI/II inhibitor, LY2109761, was purchased
from XCESSBIO in a customized quantity.
Mammary cell preparation and
flow cytometry
Mammary glands from adult mice (10-week-old)
were dissected and minced. Single-cell suspen-
sions were made by digestion of minced tissue
with culture medium [Dulbecco’s modified Eagle’s
medium (DMEM)/F12, 5% fetal bovine serum, 1%
penicillin-stretomycin-glutamine] containing colla-
genase/hyaluronidase cocktail solution (StemCell
Technolgies, 07912) for 3 hours at 37°C, followed
by sequential-5 min treatments with red blood
cell lysingbuffer (Sigma,R7767), 0.25%trypsin-EDTA,
and deoxyribonuclease (0.1 mg/ml) in dispase
(0.1 U/ml) with gentle pipetting. Cell suspension
was then filtered through 40-mm cell strainers
and applied to subsequent FACS isolation. Phyco-
erythrin (PE)/Cy7-conjugated anti-mouse CD24
(rat, clone M1/69), APC–conjugated anti-mouse
CD49f (Rat, clone GoH3), PerCP/Cy5.5 conjugated
anti-mouse CD31 (rat, clone 390), PerCP/Cy5.5 con-
jugated anti-mouse CD45 (rat, clone 30-F11), and
PerCP/Cys5.5 conjugated anti-mouseTer119 (rat,
TER-119) were purchased from BioLegend. Anti-
bodieswere then incubatedwith strainer-filtered
mammary cells in Hanks’ balanced salt solution
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Fig. 8. Mammary stem cell niche dysfunction in Gli2DS mice and CPHD patients results from stro-
mal loss of Gli2. Normal Gli2 function in mammary stroma (left) coordinates mammary stem cell
niche signaling, response to estrogen and growth hormone, and stromal expansion, leading to normal
mammary stem cell maintenance and hormone–induced growth and morphogenesis at puberty.
Stromal loss of Gli2 function in Gli2DS mice or CPHD (right) leads to disruption of the niche signaling
program and loss of mammatrophic hormone response at puberty.
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(HBSS) with 2% fetal bovine solution for 20 min
on ice. All FACS analysis and cell sortings were
performed using FACS aria II (Becton Dickinson).
EdU flow cytometry
In vivo EdU labeling was accomplished by in-
traperitoneal injection of EdU (150 mg per 10 g of
body weight). Mammary glands were collected
after 3 hours and prepared as single-cell suspen-
sions, followed by click-it chemistry for EdU
staining and surface markers–based staining
(CD24-PE/Cy7, CD49f-APC, CD31-PerCP/Cy5.5,
CD45-PerCP/Cy5.5, Ter119-PerCP/Cy5.5) to separate
stromal, luminal, and basal populations. EdU-
stained cells in the stromal-negative popula-
tion were then presented as a percentage of
parental cells.
Liquid b-Gal assay
FACS-isolated mammary stromal cells were cul-
tured ex vivo and treated with the indicated con-
centrations of TGFb with or without TGFbRI/II
inhibitor, LY2109761. Cells were lysed and in-
cubated with colorimetric b-Gal substrate, ortho-
nitrophenyl-b-galactoside (ONPG). b-Gal activity
as indicated by OD420 was measured at the in-
dicated conditions.
In vitro colony-formation assay
To compare ex vivo colony-forming activity of
mammary epithelial cells derived from different
backgrounds, we adopted an established 3D On-
Top assay (42). Briefly, Matrigel (BD Bioscience)
was thawed and applied to the bottom of 24-well
plate at a volume of 120 ml per well, followed by
polymerization at 37°C for 15 min. FACS-isolated
mammary epithelial cells were resuspended in
stock buffer (DMEM/F12, 10% FBS) at a density
of 2 × 105 cells per ml, serial diluted in Matrigel
containing buffer (DMEM/F12, 10% FBS, 50%
Matrigel), and plated on top of the polymerized
Matrigel. Culture medium was changed every
48 hours. Primary colony numbers were scored
after 14 days in culture, followed by sequential
phosphate-buffered saline (PBS)–EDTA treatment
and extraction of 3D-cultured mammary colonies
into single-cell suspensions.
Histology analysis
Gli2WT and Gli2DS mice were euthanized at the
indicated ages. The 2nd/3rd and/or the 4th mam-
mary glands were dissected. For whole-mount car-
mine alum analysis, mammary glands were fixed
in Carnoy’s fixative for 3 hours, followed by serial
rehydration, carmine alum staining, and serial
dehydration. Mammary glands were then cleared
with xylenes and mounted with permount. For
whole-mount X-Gal analysis, mammary glands
were fixed in X-Gal fixative (2% paraformaldehyde,
0.2% glutaraldehyde) for 30 min at ambient tem-
perature, followedby serial rehydration, overnight
carmine alum staining, dehydration, and clear-
ance with xylenes. For X-Gal staining, hematox-
ylin and eosin (H&E) staining, and trichrome
staining, mammary glands were fixed and cut as
paraffin sections for H&E or trichrome staining
or as cryosections for X-Gal staining. X-Gal,
H&E, and trichrome staining on mammary sec-
tions was performed as described previously (43).
Immunofluorescence and
confocal microscopy
Dissected mammary glands were fixed in 4%
paraformaldehyde, serially dehydrated, and pro-
cessed as 4-mm paraffin sections. Paraffin sections
were cleared with xylenes, rehydrated, and sub-
jected to antigen-retrieval in citric acid–based
buffer by the pressure cooker method (44). For
immunostaining, tissue sections were rinsed in
PBS, then blocked in blocking solution contain-
ing 3% bovine serum albumin (BSA), 0.25%
Triton X-100, and serum of the host species used
to generate the secondary antibody (10% goat
serum or 10% donkey serum). An hour after block-
ing, diluted primary antibodies in blocking buf-
fer were incubated with sections overnight at 4°
C in a humidified chamber. Sections were then
washed three times with PBS containing 0.25%
Triton X-100 and incubated with appropriate sec-
ondary antibodies diluted 1:1000 in blocking solu-
tion for 1 hour at ambient temperature, followedby
three washes and mounting with Prolong Gold
mountingreagentwith4′,6-diamidino-2-phenylindole
(DAPI) (Invitrogen). Immunofluorescence images
were obtained using a Zeiss LSM 510 inverted
confocalmicroscope, processed for publicationwith
Zeiss LSM5 Image Browser software, and are rep-
resentative images from one of three experiments.
Mammary fat pad transplantation
FACS-isolated cells were resuspended in a cock-
tail buffer with 50% DMEM/F12 (20%FBS), 50%
Matrigel, and 0.04% Trypan Blue (Sigma). Cells
were injected into cleared mammary gland fat
pads of 3-week-old female mice. Repopulated
mammary glands were harvested 9 weeks after
transplantation. Outgrowths of repopulated mam-
mary ductal structures were imaged under a fluo-
rescence dissection microscope (Leica). For
macrophage and stromal cell rescue assay, mac-
rophages (identified by F4/80) and Fsp1+ stro-
mal cells (identified by GFP) from the mammary
glands of Fsp-cre Gli2nLacZ/wt mTmG mice were
injected into the inguinal fat pads of 3-week-old
Gli2DS NSG recipient mice at 10,000 cells per
gland with 50% Matrigel + DMEM F12 medium.
Twomonths after the injection, mammary glands
were dissected and analyzed by whole-mount
and immunohistochemistry (IHC).
Mammary in vivo competitive
repopulation assay
Green color–labeled Lin–CD24+CD49fhighGFP+
basal cells isolated from Gli2WT mice were
mixed in equal number with red color–labeled
Lin–CD24+CD49fhiGFP+ basal cells isolated from
Gli2WT mice (green Gli2WT: red Gli2WT) or from
Gli2DS (green Gli2WT: red Gli2DS) mice. These mix-
tures were transplanted bilaterally into cleared
mammary gland fat pads of immune-deficient NSG
mice (non-obese diabetic, severe combined im-
munodeficiency, IL-2 gamma chain-deficient). Out-
growths in this competitive mammary repopulation
assay were examined 9 weeks after transplantation.
Mammary regeneration assay
Lin-CD24+CD49fhiGFP+ basal cells derived from
EGFP+micewere serially diluted as indicated and
transplanted into cleared mammary gland fat
pads ofGli2WT;NSGmice with at least one func-
tional allele of Gli2 (Gli2flox/+;NSG or Gli2nLacZ/+;
NSG) or into Gli2DS;NSG littermates (Fsp1Cre;
Gli2flox/nLacZ;NSG or Fsp1Cre;Gli2flox/flox;NSG).
Mammary outgrowth frequency and size of out-
growths were measured. Outgrowth frequency
(repopulation frequency) was calculated by L-Calc
software of StemCell Technologies. Owing to
limited numbers of matching Gli2WT;NSG and
Gli2 DS;NSGwithin a single litter, data presented
in the table summarize transplantation results
in mice from several different litters.
RNA extraction and microarray analysis
Total RNAs of FACS-isolated stromal population
from Gli2WT and Gli2DS mice were extracted by
Trizol and RNeasy Plus min kit (Qiagen). Con-
centration and quality of extracted RNAs were
determined by Agilent 2100 Bioanalyzer (Agilent
Technologies). RNA samples were hybridized to
the Mouse Gene 2.0 ST microarray chips and
scanned in accordance with the manufacturer’s
protocol (data available at www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE66820). Expression
values normalized and differentially expressed
genes were identified by Transcriptome Analysis
Console (TAC). Genes showing a fold change of
1.5 (log2) were highlighted in functional annota-
tion analyses. Expression changes of genes of
interests by microarray analysis were validated
via quantitative reverse transcription–polymerase
chain reaction (RT-PCR) analysis.
Single-cell FACS isolation and
data analysis
GFP-labeled mammary stromal cells of Gli2WT
and Gli2DS mice were FACS-isolated (5000 cells
per genotype), followed by single-cell FACS iso-
lation into 96-well plates. Sorted single cells on
a 96-plate format were lysed by hypotonic pres-
sure, and mRNA expression levels (Ct, threshold
cycle) of 48 genes in 48 cells were measured by
microfluidic single-cell RT-qPCR reaction in two
48 by 48 format Fluidigm chips (45, 46) (Fluidigm,
CA). Data analysis was performed with Matlab
(Mathworks, MA).
Slow-release polymer implantation assay
GH, IGF1, and IGF1/WNT2B were prepared as
slow-release proteins in Elvax40-based polymers
(47–49). Briefly, lyophilized BSA (20mg) alone or
in a mixture with the indicated amount of GH,
IGF1, or IGF1/WNT2Bwere dispersed in 0.125ml
of Elvax40 that had been dissolved in dichloro-
methane (20% wt/vol). The mixture was quick-
frozen and dried in a rotary evaporator, then the
polymer matrix with entrapped proteins was cut
to size (0.5 to 1 mg) and surgically implanted.
Kinetics and activities of released proteins were
validated in ELISA analyses and in qPCR anal-
yses of their target gene expression, respectively.
Control Elvax40 polymer or Elvax40 polymers
containing the above-mentioned proteins were
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implanted bilaterally into pubertal or adult Gli2DS
mice.Mammary ductalmorphologywas examined
7 days after surgery. In parallel experiments,
mammary ducts in the vicinity (1 to 2 mm) of
implants were dissected and prepared as single-cell
suspensions. Cells derived from various implants
were plated in a 24-well Petri dish for 2 hours to
deplete fibroblasts, followed by collection of super-
natant enriched in epithelial cells. Total RNAs
were extracted from epithelial cells and converted
to cDNAs, which were then applied to gene-
specific (Bio-Rad) preamplification and subse-
quent qPCR analyses.
GH, estrogen, and prolactin ELISA
analyses in serum
Peripheral blood was drawn by retro-orbital bleed-
ing in the amount of 200ml fromGli2WTandGli2DS
mice. Mice were allowed to recover for 5 days until
the next collection. Blood samples were kept at
ambient temperature for 30 min, followed by cen-
trifugation at 3000 rpm for 10 min. Serum in the
supernatant was either used immediately for
ELISA analyses or aliquoted and stored at –80°C
until next use. Serum samples were diluted and
subjected to standard ELISA assays to determine
GH or prolactin levels in accordance with the
manufacturer’s protocol. Differences between geno-
types are considered significant ifP<0.05. Estrogen
levels of Gli2WT and Gli2DS mice were determined
by 17b-Estradiol ELISA kit (from Enzolifesciences)
according to the manufacturer’s instructions.
Statistical analysis
Statistic analysis was performed with GraphPad
Prism v5. Data are presented as mean ± SEM,
and group differences were examined with a
two-tailed Student’s t test. P values were calcu-
lated on the basis of three independent experi-
ments unless otherwise specified. A value of P <
0.05 is considered statistically significant.
Primers used in real-time
RT-PCR analysis
Primers used for preamplification of Igf1, Egr1,
mCsf, and Axin2 in cDNAs of dissected implants
were purchased from Bio-Rad. Primers used for
qPCR analyses of Col1a1, Col1a2, Col2a1, Pdgfra,
Pdgfb, and Esr1were previously reported (50–52).
Others were purchased as QuantiTect Primer
Assays fromQiagen. QuantiTect primer assays used
for real-time RT-PCR include mGli2 (QT00291711),
Ghr (QT00109900),mBmp7 (QT00096026),mIgf1
(QT00154469),mWnt2 (QT00118503),mWnt2b
(QT00115451), mFgf7 (QT00172004), mHgf
(QT00158046), mEgr1 (QT00265846), mCsf1
(QT01164324),mIl-3Ra (QT00251293),mAxin2
(QT00126539), and mLef1 (QT00148834).
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